Table 2 Univariable logistic regression analysis of each indicator and diagnostic in the development cohort
Characteristic | Univariable analysis | ||
|---|---|---|---|
Odds ratio | 95% CI | P value | |
Male | 1·71 | (0·72, 4·02) | 0·222 |
Age | 1·01 | (0·98, 1·04) | 0·691 |
Treatment before | 0·53 | (0·25, 1·11) | 0·094 |
Psychiatric behaviour disorders | 3·89 | (1·70, 8·89) | 0·001 |
No symptom | 0·53 | (0·17, 1·62) | 0·263 |
Serum TPPA > 1:320 | 2·67 | (0·93, 7·64) | 0·068 |
Serum TRUST | |||
Negative | Ref | ||
1 | 1·93 | (0·41, 9·10) | 0·407 |
8 | 4·20 | (0·74, 23·91) | 0·106 |
16 | 9·00 | (1·82, 44·59) | 0·007 |
32 | 22·50 | (4·23, 119·77) | 0·000 |
64 | 49·50 | (7·15, 342·77) | < 0·0001 |
Serum creatine kinase | 1·00 | (1·00, 1·01) | 0·109 |
Elevated CK | 4·8 | (1·1, 21·8) | 0·042 |
Serum IgG | 1·03 | (0·90, 1·18) | 0·687 |
Serum albumin | 0·95 | (0·88, 1·04) | 0·284 |
CSF Protein | 6·51 | (1·77, 23·96) | 0·005 |
≤ 0·45 | Ref | ||
> 0·45 | 4·80 | (2·22, 10·36) | < 0·0001 |
CSF Glucose | 0·66 | (0·39, 1·09) | 0·105 |
CSF Nucleated cells | 1·00 | (0·99, 1·01) | 0·899 |
≤ 5 | Ref | ||
> 5 | 2·89 | (1·38, 6·08) | 0·005 |